Syndax Pharma Enters Into Privately Negotiated Subscription Agreements For Issuance Of $250M Aggregate Principal Amount Of 2.25% Convertible Senior Notes Due 2031

Loading news article.

Syndax Pharma Enters Into Privately Negotiated Subscription Agreements For Issuance Of $250M Aggregate Principal Amount Of 2.25% Convertible Senior Notes Due 2031 | WAPE

Syndax Pharma Enters Into Privately Negotiated Subscription Agreements For Issuance Of $250M Aggregate Principal Amount Of 2.25% Convertible Senior Notes Due 2031

Article summary

Related companies

Comments —